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1. Introduction 
The basic amino acids are known to have important 
roles in enzyme catalysis. Some of these residues have 
already been chemically modified in yeast phospho- 
glycerate kinase (ATP: 3-phospho-D-glycerate 1 -phos- 
photransferase, EC 2.7.2.3.). The results how that 
there are at most three essential lysyl residues per 
enzyme molecule [l] whereas adirect implication of 
a histidyl residue in the catalytic reaction of phospho- 
glycerate kinase seems improbable [2]. In this report 
the arginyl residues have been modified with 2,3- 
butanedione in borate buffer. This reagent has been 
introduced to protein studies mainly by Riordan [3] 
and it has been successfully used to identify essential 
arginyl residues in several enzymes (cf. [3- 131). Our 
results uggest an essential arginyl residue in yeast 
phosphoglycerate kinase. 
2. Materials and methods 
Ehosphoglycerate kinase from yeast was prepared 
as described previously [141. A molecular weight of 
45 000 and a molar absorptivity of 22 500 M-‘cm-’ 
were used [ 15,161. The catalytic activity was assayed 
under conditions described earlier [ 15,16,17] . All 
chemicals were of analytical grade. Only glass- 
distilled water was used. 
An ahquot from a freshly prepared and pH adjusted 
butanedioneborate solution was added to phospho- 
glycerate kinase in borate buffer to Initiate the 
modification reaction. Borate buffer has to be used 
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due to the participation of borate in the modification 
reaction [3 3. To stop the reaction, samples (25 ~1) 
were withdrawn from the reaction mixture at different 
times and added to (500 ~1) 50 mM Tris-HCl buffer 
(pH 7.8). One minute later 10 ~1 was taken for 
activity measurement. This dilution procedure did 
not result in reactivation and no change in activity 
could be seen even if the incubation time in the 
Tris-HCl buffer was increased to 30 min. Samples for 
amino acid analysis were passed through a Sephadex 
G-25 (Fine) column (1 X48 cm), equilibrated with 
50 mM borate buffer (pH 7.5), at 22°C to remove 
excess reagent. After the protein had been hydrolyzed 
in evacuated, sealed ampoules with 6 M HCl at 110°C 
for 20-22 h the amino acid contents were analysed 
on a Beckman Unichrom analyser. The degree of 
modification was followed through losses in the 
arginine content [3]. Yeast phosphoglycerate kinase 
has been reported to contain 42 lysines [ 161 and 
8 histidines [161 and using these values as a reference 
an average of 13 arginines were found. 
The proton NMR experiments were performed at 
270 MHz using a Bruker spectrometer operating in the 
Fourier transform mode. All solutions were prepared 
in 2H20 (> 99.8%) and pH was estimated by the 
addition of 0.4 to the pH meter eading. 
3. Results 
3.1. Chemical modification with butanedione in 
borate buffer 
Fhosphoglycerate kinase is rapidly inactivated at 
different concentrations of butanedione as shown in 
fig. 1. In the concentration range studied the inacti- 
vations follow pseudo-first order kinetics with respect 
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Fig.1. Inactivation of phosphoglycerate kinase with different 
concentrations of butanedione. Phosphoglycerate kinase 
(1 mg/ml) was incubated at 25°C in 50 mM borate buffer, 
(pH 7.5), with the following concentrations of butanedione: 
(v) 1.11 mM; (0) 2.22 mM; (v) 4.44 mM; (0) 8.89 mM. The 
results are presented as semi-log plots of % residual activity 
vs. time. The activity of a control sample, containing no 
butanedione, remained constant during the reaction time. 
Insert: The data of fig.1. are plotted as log 100/A vs. log B, 
where A is the half-time (min) of inactivation and B the 
butanedione concentration (mM). 
to enzyme active sites until 90 to 95% inactivation 
has occurred, and prolonged incubation results in 
complete inactivation. Several authors [ l&22,12] 
have used a plot of log (1 /tn) against log inhibitor 
concentration, where the reaction order with 
respect to inhibitor can be determined from the slope 
of the plot. Such a plot (fig.1 insert) shows a slope of 
0.82. However, a deviation from a linear relationship 
in the plot is observed and this is obvious at 8.9 mM 
butanedione. The slope at lower concentrations of 
butanedione, i.e. the initial slope, is closer to 1 .O than 
to 0.82. These results indicate that not more than one 
molecule of butanedione per active site of the enzyme 
is necessary for inactivation. A similar saturation effect 
as above has been reported with alcohol dehydrogenase 
[6] at higher concentrations (10 mM) of butanedione. 
To test the reversibility of the modification, phos- 
phoglycerate kinase was modified with 4.44 mM 
butanedione, under conditions described in fig. 1, until 
a residual activity of 10% was obtained. At this time 
the reaction mixture was passed through a Sephadex 
G-25 column (1 X48 cm), which was equilibrated with 
50 mM Tris-HCl buffer (pH 7.5). Incubation of the 
eluted enzyme at 25’C for 6 to 7 h reactivates phos- 
phoglycerate kinase to 9% of the original activity. 
However, no reactivation is observed if 50 mM borate 
buffer (pH 7.5) is used in the gel filtration instead of 
the Tris-HCl buffer. 
3.2. Amino acid analyses of the modified enzyme 
A correlation of the decrease in activity with the 
modification of arginyl residues is demonstrated in 
fig.2. More than two arginyl residues seem to be 
modified before complete inactivation is obtained. 
However, extrapolation to zero activity of the initial 
slope of the plot, which is responsible for the major 
decrease in activity, shows that the loss of activity 
is the result of 1 .O modified arginyl residue per 
enzyme molecule. The ratio of histidine to lysine 
remained constant throughout these experiments. 
No detectable change could be observed for any 
other amino acid. 
3.3. i%e effect of substrates on the reaction with 
butanedione 
MgATP, MgADP and 3-phospho-D-glycerate are 
each effective in slowing down the inactivation 
reactions as illustrated in fig.3. The degree of protec- 
tion is in reasonable agreement with the degree of 
substrate binding if one assumes that the previously 
reported Km values [23,24] approximately represent 
1 NUMBER MODIFIED ARGINYL RESIDUES/ENZYME 
Fig.2. Correlation of the inactivation of phosphoglycerate 
kinase with the modification of arginyl residues. Samples 
were withdrawn for amino acid analyses (see Materials and 
methods) from the reaction of phosphoglycerate kinase with 
4.44 mM butanedione (1.11 mM were used occasionally) 
under conditions described in fig.1. The points represent he 
average values from two independent runs. 
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Fig.3. Inactivation of phosphoglycerate kinase with butane- 
dione in the presence of substrates. The enzyme was modified 
with 4.44 mM butanedione, under conditions described in 
fig.1, with the following concentrations f substrates: (v)
none; (0) 7 mM MgATP; (0) 21 mM MgATP; (=) 11 mM 
3-phospho-D-glycerate; (r) 33 mM 3-phospho-D-glycerate; 
(0) 8 mM MgADP. The results are presented as semi-log plots 
of % residual activity vs. time. Some experimental values 
have been left out of the figure for clarity. 
the dissociation constants. A similar protection is 
found with a dead-end mixture of a substrate and a 
product. Thus, a solution containing 9 mM ADP, 
9 mM Mg and 33 mM 3-phospho-D-glycerate delays 
the reaction with butanedione to the same extent as 
33 mM 3-phospho-D-glycerate does under correspond- 
ing conditions. Apparently all of these substrates are 
capable of protecting an arginyl residue from being 
modified. This is further demonstrated by a direct 
comparison of the degree of mbdification in the 
presence and absence of substrates. The results are 
summarized in table 1. Although the standard 
deviations are rather high it seems clear that at least 
one arginyl residue less is modified in the presence 
of either MgATP or 3-phospho-D-glycerate. 
To test for a possible interaction of borate with 
the substrates, NMR spectra t 270 MHz of 21 mM 
MgATP, 33 mM 3-phospho-D-glycerate nd 50 mM 
NAD’, respectively, were recorded in both 50 mM 
borate buffer (pH 7.5) and 50 mM Tris-DC1 (pH 7.5). 
No changes in the spectra of MgATP and 3-phospho- 
D-glycerate could be detected, implying that the 
decrease in reaction rate in the presence of substrates 
does not result from a decrease in the borate concen- 
Modification of arginyl residues in phosphoglycerate kinase 
in the presence and absence of substrates 
Substrate Number of arginyl residues per enzyme 
molecule 
Modified Protected 
None 1.6 f 0.30 
21 mM MgATP 0.5 + 0.14 1.1 + 0.44 
33 mM 3-phospho- 
Dglycerate 0.3 f 0.09 1.3 f 0.39 
Phosphoglycerate kinase (1 mg/ml) was modified with 4.44 
mM butanedione in 50 mM borate buffer (pH 7.5) at 25°C 
for 35 min in the presence of different substrates. The 
sample standard deviations (S.D.) are calculated from three 
independent runs. 
tration. The NAD’ spectra, on the other hand, showed 
noticeable differences. Borate is known to interact 
with NAD’, preferentially with the ribose adjacent to 
the nicotinamide moiety [25,26]. 
4. Discussion 
The observation of pseudo-first order kinetics 
during 90 to 95% of the inactivation reaction, the 
known selectivity of butanedione and the high degree 
of reversibility of the modification reaction strongly 
suggest that no major conformational changes occur 
parallel with the modification. The reaction order 
with respect o butanedione suggests hat inactivation 
is the result of one modified arginyl residue per 
active site of the enzyme. The amino acid analyses 
show that the loss of activity is correlated with the 
modification of one arginyl residue per enzyme 
molecule. Furthermore, MgATP and 3-phospho-D- 
glycerate can each protect approximately one arginyl 
residue from modification and simultaneously nearly 
no activity is lost. The evidence presented in this work 
strongly support he idea of an essential rginyl residue 
in phosphoglycerate kinase. However, the exact func- 
tion of this residue is not known at present. Borders 
and Riordan [ 1 I] have postulated that arginyl residues 
are generally involved in the binding of ATP by 
providing a positive charge to interact with the negative 
oligophosphate moiety of the nucleotide (cf. [ 161). 
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Our results are in accordance with this postulate. 
However, the fact that 3-phospho-D-glycerate 
protects to an almost similar degree as MgATP 
suggests an even further involvement of this essential 
residue in the catalytic mechanism of phospho- 
glycerate kinase. 
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